# Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma

> **NCT02250599** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 80 (estimated)

## Conditions studied

- Nasopharyngeal Neoplasms

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Bevacizumab
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT02250599
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2016-04
- **Final completion:** 2016-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2015-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02250599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02250599, "Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT02250599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*